Hacked Medical Pumps Could Kill You

  6/11/2015 Billy Rios, a security expert conducting research on medical devices manufactured by Hospira, found deadly serious security flaws in drug delivery pumps. In short: hacked medical pumps could kill you. Currently, there are hundreds of thousands of Hospira pumps in hospitals throughout the U.S. I wrote a piece last month regarding an FDA


Ford Motor Company Recalls Almost 423K Vehicles

6/2/2015 Ford Motor Company recalls almost 423K vehicles in North America due to potential power steering failure. There is an intermittent electrical connection that can fail, putting the vehicles into manual steering mode thus making them harder to control. Ford reports four known crashes, but no injuries. The recall covers the following vehicles: Ford Flex



Zerbaxa Labels Cause Confusion Over Dosages

5/21/2015 The FDA announced yesterday that it is warning healthcare professionals of potential problems with Zerbaxa (ceftolozane and tazobactam). Apparently, the Zerbaxa labels cause confusion over dosages. The risk stems from the vial label being approved with each individual active ingredients’ strength listed (e.g. 1 g/0.5 g). The product is not dosed like that, though,


FDA Posted an Alert Regarding Hospira’s LifeCare PCA3 and PCA5 Infusion Pumps

5/21/2015 Earlier this month, the FDA posted an alert regarding Hospira’s LifeCare PCA3 and PCA5 infusion pumps. The computerized systems are used to continuously deliver anesthetic or therapeutic drugs and can be programmed remotely over a hospital’s Ethernet or wireless service. Both Hospira and the FDA learned of certain security vulnerabilities in Hospira’s PCA3 and


SGLT2 Drugs Have Negative History with FDA

  5/21/2015 Quite surprising to me, I found that SGLT2 drugs have negative history with FDA. Not surprising, especially after finding the history, is the warning FDA released earlier this week. It appears that canagliflozin, sold as Invokana, may have created problems in the clinical trials that should have prevented its release. Just as other


Treatment Regimen for SGLT2-Related Ketoacidosis

5/19/2015 Yesterday we wrote about the warning issued by the FDA regarding SGLT2 type 2 diabetes medications. Today, I want to share the treatment regimen for SGLT2-related ketoacidosis. Always consult your physician before making changes in any medication protocol. If you find yourself experiencing any of the symptoms of ketoacidosis, get to the emergency room



General Motors Issued Two Recalls Today

 5/13/2015 General Motors issued two recalls today. One deals with seats that may not be anchored properly and the other is for potentially defective seat belts. This latest bout of recalls includes roughly 525K vehicles, compared to the company’s 2014 record-breaking recall total of 26.95M vehicles. The first of the vehicles being recalled is the